1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Transthyretin Amyloidosis (ATTR) Market Size Growth Rate by Type: 2020 VS 2026 1.2.2 Hereditary ATTR (HATTR) 1.2.3 Wild-Type (WT) ATTR 1.3 Market by Application 1.3.1 Global Transthyretin Amyloidosis (ATTR) Market Share by Application: 2020 VS 2026 1.3.2 Hospitals 1.3.3 Ambulatory Surgical Centers 1.3.4 Diagnostic Centers 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Transthyretin Amyloidosis (ATTR) Market Perspective (2015-2026) 2.2 Global Transthyretin Amyloidosis (ATTR) Growth Trends by Regions 2.2.1 Transthyretin Amyloidosis (ATTR) Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Transthyretin Amyloidosis (ATTR) Historic Market Share by Regions (2015-2020) 2.2.3 Transthyretin Amyloidosis (ATTR) Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Transthyretin Amyloidosis (ATTR) Players by Market Size 3.1.1 Global Top Transthyretin Amyloidosis (ATTR) Players by Revenue (2015-2020) 3.1.2 Global Transthyretin Amyloidosis (ATTR) Revenue Market Share by Players (2015-2020) 3.2 Global Transthyretin Amyloidosis (ATTR) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Transthyretin Amyloidosis (ATTR) Revenue 3.4 Global Transthyretin Amyloidosis (ATTR) Market Concentration Ratio 3.4.1 Global Transthyretin Amyloidosis (ATTR) Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Transthyretin Amyloidosis (ATTR) Revenue in 2019 3.5 Key Players Transthyretin Amyloidosis (ATTR) Area Served 3.6 Key Players Transthyretin Amyloidosis (ATTR) Product Solution and Service 3.7 Date of Enter into Transthyretin Amyloidosis (ATTR) Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Transthyretin Amyloidosis (ATTR) Breakdown Data by Type (2015-2026) 4.1 Global Transthyretin Amyloidosis (ATTR) Historic Market Size by Type (2015-2020) 4.2 Global Transthyretin Amyloidosis (ATTR) Forecasted Market Size by Type (2021-2026) 5 Transthyretin Amyloidosis (ATTR) Breakdown Data by Application (2015-2026) 5.1 Global Transthyretin Amyloidosis (ATTR) Historic Market Size by Application (2015-2020) 5.2 Global Transthyretin Amyloidosis (ATTR) Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Transthyretin Amyloidosis (ATTR) Market Size (2015-2026) 6.2 North America Transthyretin Amyloidosis (ATTR) Market Size by Type (2015-2020) 6.3 North America Transthyretin Amyloidosis (ATTR) Market Size by Application (2015-2020) 6.4 North America Transthyretin Amyloidosis (ATTR) Market Size by Country (2015-2020) 6.4.1 United States 6.4.2 Canada 7 Europe 7.1 Europe Transthyretin Amyloidosis (ATTR) Market Size (2015-2026) 7.2 Europe Transthyretin Amyloidosis (ATTR) Market Size by Type (2015-2020) 7.3 Europe Transthyretin Amyloidosis (ATTR) Market Size by Application (2015-2020) 7.4 Europe Transthyretin Amyloidosis (ATTR) Market Size by Country (2015-2020) 7.4.1 Germany 7.4.2 France 7.4.3 U.K. 7.4.4 Italy 7.4.5 Russia 7.4.6 Nordic 7.4.7 Rest of Europe 8 China 8.1 China Transthyretin Amyloidosis (ATTR) Market Size (2015-2026) 8.2 China Transthyretin Amyloidosis (ATTR) Market Size by Type (2015-2020) 8.3 China Transthyretin Amyloidosis (ATTR) Market Size by Application (2015-2020) 8.4 China Transthyretin Amyloidosis (ATTR) Market Size by Region (2015-2020) 8.4.1 China 8.4.2 Japan 8.4.3 South Korea 8.4.4 Southeast Asia 8.4.5 India 8.4.6 Australia 8.4.7 Rest of Asia-Pacific 9 Japan 9.1 Japan Transthyretin Amyloidosis (ATTR) Market Size (2015-2026) 9.2 Japan Transthyretin Amyloidosis (ATTR) Market Size by Type (2015-2020) 9.3 Japan Transthyretin Amyloidosis (ATTR) Market Size by Application (2015-2020) 9.4 Japan Transthyretin Amyloidosis (ATTR) Market Size by Country (2015-2020) 9.4.1 Mexico 9.4.2 Brazil 10 Southeast Asia 10.1 Southeast Asia Transthyretin Amyloidosis (ATTR) Market Size (2015-2026) 10.2 Southeast Asia Transthyretin Amyloidosis (ATTR) Market Size by Type (2015-2020) 10.3 Southeast Asia Transthyretin Amyloidosis (ATTR) Market Size by Application (2015-2020) 10.4 Southeast Asia Transthyretin Amyloidosis (ATTR) Market Size by Country (2015-2020) 10.4.1 Turkey 10.4.2 Saudi Arabia 10.4.3 UAE 10.4.4 Rest of Middle East & Africa 11 Key Players Profiles 11.1 Pfizer 11.1.1 Pfizer Company Details 11.1.2 Pfizer Business Overview 11.1.3 Pfizer Transthyretin Amyloidosis (ATTR) Introduction 11.1.4 Pfizer Revenue in Transthyretin Amyloidosis (ATTR) Business (2015-2020)) 11.1.5 Pfizer Recent Development 11.2 Alnylam Pharmaceuticals 11.2.1 Alnylam Pharmaceuticals Company Details 11.2.2 Alnylam Pharmaceuticals Business Overview 11.2.3 Alnylam Pharmaceuticals Transthyretin Amyloidosis (ATTR) Introduction 11.2.4 Alnylam Pharmaceuticals Revenue in Transthyretin Amyloidosis (ATTR) Business (2015-2020) 11.2.5 Alnylam Pharmaceuticals Recent Development 11.3 Ionis Pharmaceuticals 11.3.1 Ionis Pharmaceuticals Company Details 11.3.2 Ionis Pharmaceuticals Business Overview 11.3.3 Ionis Pharmaceuticals Transthyretin Amyloidosis (ATTR) Introduction 11.3.4 Ionis Pharmaceuticals Revenue in Transthyretin Amyloidosis (ATTR) Business (2015-2020) 11.3.5 Ionis Pharmaceuticals Recent Development 11.4 Corino Therapeutics 11.4.1 Corino Therapeutics Company Details 11.4.2 Corino Therapeutics Business Overview 11.4.3 Corino Therapeutics Transthyretin Amyloidosis (ATTR) Introduction 11.4.4 Corino Therapeutics Revenue in Transthyretin Amyloidosis (ATTR) Business (2015-2020) 11.4.5 Corino Therapeutics Recent Development 11.5 Proclara Bioscience 11.5.1 Proclara Bioscience Company Details 11.5.2 Proclara Bioscience Business Overview 11.5.3 Proclara Bioscience Transthyretin Amyloidosis (ATTR) Introduction 11.5.4 Proclara Bioscience Revenue in Transthyretin Amyloidosis (ATTR) Business (2015-2020) 11.5.5 Proclara Bioscience Recent Development 11.6 Arcturus Therapeutics 11.6.1 Arcturus Therapeutics Company Details 11.6.2 Arcturus Therapeutics Business Overview 11.6.3 Arcturus Therapeutics Transthyretin Amyloidosis (ATTR) Introduction 11.6.4 Arcturus Therapeutics Revenue in Transthyretin Amyloidosis (ATTR) Business (2015-2020) 11.6.5 Arcturus Therapeutics Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Transthyretin Amyloidosis (ATTR) Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 3. Key Players of Hereditary ATTR (HATTR) Table 4. Key Players of Wild-Type (WT) ATTR Table 5. Global Transthyretin Amyloidosis (ATTR) Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 6. Global Transthyretin Amyloidosis (ATTR) Market Size by Regions (US$ Million): 2020 VS 2026 Table 7. Global Transthyretin Amyloidosis (ATTR) Market Size by Regions (2015-2020) (US$ Million) Table 8. Global Transthyretin Amyloidosis (ATTR) Market Share by Regions (2015-2020) Table 9. Global Transthyretin Amyloidosis (ATTR) Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 10. Global Transthyretin Amyloidosis (ATTR) Market Share by Regions (2021-2026) Table 11. Transthyretin Amyloidosis (ATTR) Market Market Trends Table 12. Transthyretin Amyloidosis (ATTR) Market Drivers Table 13. Transthyretin Amyloidosis (ATTR) Market Challenges Table 14. Transthyretin Amyloidosis (ATTR) Market Restraints Table 15. Global Transthyretin Amyloidosis (ATTR) Revenue by Players (2015-2020) (US$ Million) Table 16. Global Transthyretin Amyloidosis (ATTR) Market Share by Players (2015-2020) Table 17. Global Top Transthyretin Amyloidosis (ATTR) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transthyretin Amyloidosis (ATTR) as of 2019) Table 18. Global Transthyretin Amyloidosis (ATTR) by Players Market Concentration Ratio (CR5 and HHI) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Transthyretin Amyloidosis (ATTR) Product Solution and Service Table 21. Mergers & Acquisitions, Expansion Plans Table 22. Global Transthyretin Amyloidosis (ATTR) Market Size by Type (2015-2020) (US$ Million) Table 23. Global Transthyretin Amyloidosis (ATTR) Market Size Share by Type (2015-2020) Table 24. Global Transthyretin Amyloidosis (ATTR) Revenue Market Share by Type (2021-2026) Table 25. Global Transthyretin Amyloidosis (ATTR) Market Size Share by Application (2015-2020) Table 26. Global Transthyretin Amyloidosis (ATTR) Market Size by Application (2015-2020) (US$ Million) Table 27. Global Transthyretin Amyloidosis (ATTR) Market Size Share by Application (2021-2026) Table 28. North America Transthyretin Amyloidosis (ATTR) Market Size by Type (2015-2020) (US$ Million) Table 29. North America Transthyretin Amyloidosis (ATTR) Market Share by Type (2015-2020) Table 30. North America Transthyretin Amyloidosis (ATTR) Market Size by Application (2015-2020) (US$ Million) Table 31. North America Transthyretin Amyloidosis (ATTR) Market Share by Application (2015-2020) Table 32. North America Transthyretin Amyloidosis (ATTR) Market Size by Country (US$ Million) (2015-2020) Table 33. North America Transthyretin Amyloidosis (ATTR) Market Share by Country (2015-2020) Table 34. Europe Transthyretin Amyloidosis (ATTR) Market Size by Type (2015-2020) (US$ Million) Table 35. Europe Transthyretin Amyloidosis (ATTR) Market Share by Type (2015-2020) Table 36. Europe Transthyretin Amyloidosis (ATTR) Market Size by Application (2015-2020) (US$ Million) Table 37. Europe Transthyretin Amyloidosis (ATTR) Market Share by Application (2015-2020) Table 38. Europe Transthyretin Amyloidosis (ATTR) Market Size by Country (US$ Million) (2015-2020) Table 39. Europe Transthyretin Amyloidosis (ATTR) Market Share by Country (2015-2020) Table 40. China Transthyretin Amyloidosis (ATTR) Market Size by Type (2015-2020) (US$ Million) Table 41. China Transthyretin Amyloidosis (ATTR) Market Share by Type (2015-2020) Table 42. China Transthyretin Amyloidosis (ATTR) Market Size by Application (2015-2020) (US$ Million) Table 43. China Transthyretin Amyloidosis (ATTR) Market Share by Application (2015-2020) Table 44. China Transthyretin Amyloidosis (ATTR) Market Size by Region (US$ Million) (2015-2020) Table 45. China Transthyretin Amyloidosis (ATTR) Market Share by Region (2015-2020) Table 46. Japan Transthyretin Amyloidosis (ATTR) Market Size by Type (2015-2020) (US$ Million) Table 47. Japan Transthyretin Amyloidosis (ATTR) Market Share by Type (2015-2020) Table 48. Japan Transthyretin Amyloidosis (ATTR) Market Size by Application (2015-2020) (US$ Million) Table 49. Japan Transthyretin Amyloidosis (ATTR) Market Share by Application (2015-2020) Table 50. Japan Transthyretin Amyloidosis (ATTR) Market Size by Country (US$ Million) (2015-2020) Table 51. Japan Transthyretin Amyloidosis (ATTR) Market Share by Country (2015-2020) Table 52. Southeast Asia Transthyretin Amyloidosis (ATTR) Market Size by Type (2015-2020) (US$ Million) Table 53. Southeast Asia Transthyretin Amyloidosis (ATTR) Market Share by Type (2015-2020) Table 54. Southeast Asia Transthyretin Amyloidosis (ATTR) Market Size by Application (2015-2020) (US$ Million) Table 55. Southeast Asia Transthyretin Amyloidosis (ATTR) Market Share by Application (2015-2020) Table 56. Southeast Asia Transthyretin Amyloidosis (ATTR) Market Size by Country (US$ Million) (2015-2020) Table 57. Southeast Asia Transthyretin Amyloidosis (ATTR) Market Share by Country (2015-2020) Table 58. Pfizer Company Details Table 59. Pfizer Business Overview Table 60. Pfizer Product Table 61. Pfizer Revenue in Transthyretin Amyloidosis (ATTR) Business (2015-2020) (US$ Million) Table 62. Pfizer Recent Development Table 63. Alnylam Pharmaceuticals Company Details Table 64. Alnylam Pharmaceuticals Business Overview Table 65. Alnylam Pharmaceuticals Product Table 66. Alnylam Pharmaceuticals Revenue in Transthyretin Amyloidosis (ATTR) Business (2015-2020) (US$ Million) Table 67. Alnylam Pharmaceuticals Recent Development Table 68. Ionis Pharmaceuticals Company Details Table 69. Ionis Pharmaceuticals Business Overview Table 70. Ionis Pharmaceuticals Product Table 71. Ionis Pharmaceuticals Revenue in Transthyretin Amyloidosis (ATTR) Business (2015-2020) (US$ Million) Table 72. Ionis Pharmaceuticals Recent Development Table 73. Corino Therapeutics Company Details Table 74. Corino Therapeutics Business Overview Table 75. Corino Therapeutics Product Table 76. Corino Therapeutics Revenue in Transthyretin Amyloidosis (ATTR) Business (2015-2020) (US$ Million) Table 77. Corino Therapeutics Recent Development Table 78. Proclara Bioscience Company Details Table 79. Proclara Bioscience Business Overview Table 80. Proclara Bioscience Product Table 81. Proclara Bioscience Revenue in Transthyretin Amyloidosis (ATTR) Business (2015-2020) (US$ Million) Table 82. Proclara Bioscience Recent Development Table 83. Arcturus Therapeutics Company Details Table 84. Arcturus Therapeutics Business Overview Table 85. Arcturus Therapeutics Product Table 86. Arcturus Therapeutics Revenue in Transthyretin Amyloidosis (ATTR) Business (2015-2020) (US$ Million) Table 87. Arcturus Therapeutics Recent Development Table 88. Research Programs/Design for This Report Table 89. Key Data Information from Secondary Sources Table 90. Key Data Information from Primary Sources List of Figures Figure 1. Global Transthyretin Amyloidosis (ATTR) Market Share by Type: 2020 VS 2026 Figure 2. Hereditary ATTR (HATTR) Features Figure 3. Wild-Type (WT) ATTR Features Figure 4. Global Transthyretin Amyloidosis (ATTR) Market Share by Application: 2020 VS 2026 Figure 5. Hospitals Case Studies Figure 6. Ambulatory Surgical Centers Case Studies Figure 7. Diagnostic Centers Case Studies Figure 8. Transthyretin Amyloidosis (ATTR) Report Years Considered Figure 9. Global Transthyretin Amyloidosis (ATTR) Market Size (US$ Million), YoY Growth 2015-2026 Figure 10. Global Transthyretin Amyloidosis (ATTR) Market Share by Regions: 2020 VS 2026 Figure 11. Global Transthyretin Amyloidosis (ATTR) Market Share by Regions (2021-2026) Figure 12. Global Transthyretin Amyloidosis (ATTR) Market Share by Players in 2019 Figure 13. Global Top Transthyretin Amyloidosis (ATTR) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transthyretin Amyloidosis (ATTR) as of 2019 Figure 14. The Top 10 and 5 Players Market Share by Transthyretin Amyloidosis (ATTR) Revenue in 2019 Figure 15. North America Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2015-2026) & (US$ Million) Figure 16. United States Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2015-2026) & (US$ Million) Figure 17. Canada Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2015-2026) & (US$ Million) Figure 18. Europe Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2015-2026) & (US$ Million) Figure 19. Germany Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2015-2026) & (US$ Million) Figure 20. France Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2015-2026) & (US$ Million) Figure 21. U.K. Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2015-2026) & (US$ Million) Figure 22. Italy Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2015-2026) & (US$ Million) Figure 23. Russia Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2015-2026) & (US$ Million) Figure 24. Nordic Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2015-2026) & (US$ Million) Figure 25. Rest of Europe Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2015-2026) & (US$ Million) Figure 26. Asia-Pacific Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2015-2026) & (US$ Million) Figure 27. China Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2015-2026) & (US$ Million) Figure 28. Japan Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2015-2026) & (US$ Million) Figure 29. South Korea Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2015-2026) & (US$ Million) Figure 30. Southeast Asia Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2015-2026) & (US$ Million) Figure 31. India Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2015-2026) & (US$ Million) Figure 32. Australia Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2015-2026) & (US$ Million) Figure 33. Rest of Asia-Pacific Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2015-2026) & (US$ Million) Figure 34. Latin America Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2015-2026) & (US$ Million) Figure 35. Mexico Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2015-2026) & (US$ Million) Figure 36. Brazil Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2015-2026) & (US$ Million) Figure 37. Middle East & Africa Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2015-2026) & (US$ Million) Figure 38. Turkey Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2015-2026) & (US$ Million) Figure 39. Saudi Arabia Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2015-2026) & (US$ Million) Figure 40. UAE Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2015-2026) & (US$ Million) Figure 41. Rest of Middle East & Africa Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2015-2026) & (US$ Million) Figure 42. Pfizer Revenue Growth Rate in Transthyretin Amyloidosis (ATTR) Business (2015-2020) Figure 43. Alnylam Pharmaceuticals Revenue Growth Rate in Transthyretin Amyloidosis (ATTR) Business (2015-2020) Figure 44. Ionis Pharmaceuticals Revenue Growth Rate in Transthyretin Amyloidosis (ATTR) Business (2015-2020) Figure 45. Corino Therapeutics Revenue Growth Rate in Transthyretin Amyloidosis (ATTR) Business (2015-2020) Figure 46. Proclara Bioscience Revenue Growth Rate in Transthyretin Amyloidosis (ATTR) Business (2015-2020) Figure 47. Arcturus Therapeutics Revenue Growth Rate in Transthyretin Amyloidosis (ATTR) Business (2015-2020) Figure 48. Bottom-up and Top-down Approaches for This Report Figure 49. Data Triangulation Figure 50. Key Executives Interviewed

Pfizer Alnylam Pharmaceuticals Ionis Pharmaceuticals Corino Therapeutics Proclara Bioscience Arcturus Therapeutics